A webcast of United Technologies Corp. (NYSE:UTX) Senior Vice President and Chief Financial Officer Greg Hayes speaking at the Deutsche Bank Global Industrials & Basic Materials Conference is scheduled for 8:45 a.m. ET on Thursday, June 5, 2014. The presentation will be broadcast live on the Internet at www.utc.comand will be archived on the website.United Technologies Corporation (NYSE:UTX) net profit margin is 9.00% and weekly performance is 1.03%. On last trading day company shares ended up $116.22. Analysts mean target price for the company is $128.80. United Technologies Corporation (NYSE:UTX) distance from 50-day simple moving average (SMA50) is 0.19%.
On May 21, 2014 FONAR Corporation (NASDAQ:FONR), The Inventor of MR Scanning™, reported that after being diagnosed in November 2012 on the FONAR UPRIGHT® Multi-Position™ MRI (aka STAND-UP MRI®), former NFL quarterback, Jim McMahon, who suffered from post concussion dementia, was able to receive appropriate treatment and that his symptoms have resolved. Fonar Corporation (NASDAQ:FONR) shares fell -2.19% in last trading session and ended the day on $12.95. Gross Margin is 46.00% and its return on assets is 13.10%. Fonar Corporation (NASDAQ:FONR) quarterly performance is -42.85%.
On May 15, Hologic, Inc. (NASDAQ:HOLX) announced that its new Tomcat instrument will be showcased at the 114(th) General Meeting of the American Society for Microbiology (asm2014) at the Boston Convention and Exhibit Center, in Boston, Massachusetts from May 17 – 20(th). The Tomcat instrument is a fully automated general purpose platform designed to ease the strain of pre-analytical sample processing by eliminating the inefficient and error-prone activities required to manually aliquot samples. The Company expects to begin commercial shipments of the Tomcat instrument in June 2014. Hologic, Inc. (NASDAQ:HOLX) shares moved up 0.78% in last trading session and was closed at $24.44, while trading in range of $24.16 – $24.59. Hologic, Inc. (NASDAQ:HOLX) year to date (YTD) performance is 9.35%.
CEO Joe Kaeser of Siemens AG (ADR) (OTCMKTS:SIEGY) attempted to lower the fears of losses of jobs through a letter to his employees on Friday. This came a day after Kaeser remarked during a conference of investors that the current affects of the company’s restructuring affected close to 12,000 jobs at the industrial conglomerate located in Germany. Siemens AG (ADR) (OTCMKTS:SIEGY) ended the last trading day at $132.92 .
On May 29, Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that Thomas Tulip, President and Chief Business Officer, will participate at the Jefferies 2014 Global Healthcare Conference June 2-5, 2014 at the Grand Hyatt in New York City, NY. Dr. Tulip will present a Company update on Thursday, June 5, 2014 at 1:30 PM EDT. Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) weekly performance is 16.06%. On last trading day company shares ended up $1.59. Analysts mean target price for the company is $2.81. Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) distance from 50-day simple moving average (SMA50) is -4.60%.